Ocera gets bullish coverage at Stifel, shares rise

|About: Ocera Therapeutics, Inc. (OCRX)|By:, SA News Editor

Shares of Ocera Therapeutics (OCRX +5.8%) are notably higher in early trading.

Helping the cause is Stifel, where analysts have initiated coverage at Buy.

Price target is $19, representing upside of 62% from Friday's close.